We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Partnership to Simplify Complex DNA Microarray Analyses

By LabMedica International staff writers
Posted on 14 Jul 2011
Print article
A partnership between American and British biotech companies will automate and simplify the complex and error-prone manual steps previously required for performing DNA microarray analyses.

BlueGnome (Cambridge, United Kingdom) has announced the signing of a supply agreement with SciGene (Sunnyvale, CA, USA). SciGene will manufacture BlueGnome’s new range of ClearHyb hybridization and wash systems.

Previously SciGene had noted that BlueGnome’s recommended manual labeling, hybridization, and posthybridization processing methods for its CytoChip test required a collection of laboratory equipment and supplies including staining dishes, slide boxes, stirrers, Coplin jars, a water bath, and an oven that need to be collected, cleaned, and assembled for each run. Once set up, the procedure was technically challenging with many handling steps including the use of seven different washes with careful monitoring of buffer temperatures. The complexity of the methods provided multiple entry points for variability that could lead to ambiguous patient results and a higher cost per test.

The new partnership was designed to eliminate this ambiguity by automating and simplifying the complex and error-prone manual steps from sample preparation through slide processing for improved test reliability and lowered cost.

Nick Haan, CEO of BlueGnome, said, “Time to market is a major issue for new laboratories that wish to establish and evolve their microarray-based services. With sales to 39 countries so far this year, we find that new laboratories are increasingly looking for a complete turnkey solution, including laboratory hardware, which enables their newly trained scientists to deliver the highest quality results in the shortest possible timeframe. We have long recommended SciGene products as the best available solution for hybridization and washing of our microarrays and are excited to be working with them to strengthen this relationship with new ClearHyb products.”

Dr. Jim Stanchfield, president and CEO of SciGene, said, “We are pleased with our partnership whereby SciGene technology will be used to simplify the microarray workflow used with BlueGnome’s array solutions that will enhance the reproducibility of these assays and their customers’ laboratory productivity.”

Related Links:
BlueGnome
SciGene

Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Automated Blood Typing System
IH-500 NEXT
New
Urine Bone Markers Control
Lyphochek Urine Bone Markers Control
New
Chlamydia Test Kit
CHLAMYTOP

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.